{"id":27856,"date":"2026-03-09T01:37:08","date_gmt":"2026-03-09T01:37:08","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/27856\/"},"modified":"2026-03-09T01:37:08","modified_gmt":"2026-03-09T01:37:08","slug":"from-polyu-research-to-geneva-global-debut-good-vision-oka%c2%b3y-redefines-precision-in-freeform-orthokeratology","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/27856\/","title":{"rendered":"From PolyU Research to Geneva Global Debut: GOOD Vision oka\u00b3y! \u2122 Redefines Precision in Freeform Orthokeratology"},"content":{"rendered":"

<\/p>\n

\"No<\/p>\n

<\/a><\/p>\n

GENEVA, SWITZERLAND – Media OutReach Newswire<\/a> – 9 March 2026 – GOOD Vision Technologies Co., Limited, a pioneer in ophthalmic optics and diagnostics, today announced the global debut of oka\u00b3y!\u2122, a first-of-its-kind “3A” Freeform Orthokeratology (Ortho-K) solution. Unveiled at the 51st International Exhibition of Inventions in Geneva, the technology solves the industry’s most persistent hurdles by leveraging proprietary AI and freeform optics: AI-guided fitting, Astigmatic precision, and Asymmetric cornea alignment.<\/p>\n

Beyond Traditional Toric Lenses: The Future of Freeform Orthokeratology<\/p>\n

Get the latest news
\n

\n delivered to your inbox<\/p>\n

Sign up for The Manila Times newsletters<\/p>\n

By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service<\/a> and Privacy Policy<\/a>.<\/p>\n

With myopia expected to affect 50% of the world’s population by 2050, demand for effective management is high. While Ortho-K is a highly effective strategy, traditional symmetric and spherical\/ toric designs often underestimate corneal shape complexity, causing lens decentration and poor visual outcomes.<\/p>\n

The oka\u00b3y!\u2122 freeform technology, incorporating the company’s proprietary FAST-360 and CORe Technology, surpasses traditional lens design. AI-based FAST-360 reconstructs missing corneal data for faster scans, while CORe ensures precise alignment with the visual axis, leading to 3.1 times greater stability.<\/p>\n

Precision Myopia Correction and Control for High Astigmatism and Asymmetric Corneas<\/p>\n

For optometrists and clinic owners, oka\u00b3y!\u2122’s key benefit is improving workflow by automating complex mathematics, cutting chair time by 64%. This boosts myopia management capacity without extra staff or lengthy training. “As a registered optometrist in Hong Kong and a researcher in one of the world’s leading optometric institutes, I witnessed a growing gap between the number of patients seeking Ortho-K and the limited range of conventional products available to treat them,” says Dr. Kin Ho Chan, Ken, the lead inventor of oka\u00b3y!\u2122. “By focusing on the ‘3A’: AI-guided, Astigmatism, and Asymmetry, and working alongside The Hong Kong Polytechnic University (Poly U), we have developed a design that not only delivers superior vision but also enhances safety by reducing corneal staining. We are turning a frustrating, manual trial-and-error process into a predictable one-click adjustment.”<\/p>\n

From Niche Specialty to Global Enterprise: Scaling the Future of Eye Care <\/p>\n

As myopia rates reach epidemic levels, GOOD Vision partners with PolyU, harnessing its research strengths and support from its startup ecosystem PolyVentures, to redefine primary eye care by transforming a niche specialty into a scalable global enterprise. By replacing manual OK lens design with oka\u00b3y!\u2122, the company has created a technology bridging clinical complexity and scalability. This transition enables practitioners to manage myopia, high astigmatism, and asymmetrical cases precisely, removing barriers to modern refractive error management.<\/p>\n

“By embedding and automating the complex mathematics of lens design, we provide clinicians with the tools to treat ‘difficult’ patients who were previously considered unsuitable for Ortho-K,” added Professor Chea-su Kee, Founder of GOOD Vision. “This is about elevating the global standard of care and ensuring that precision myopia management is accessible to the next generation on a global scale.”<\/p>\n

Experience the Future of Myopia Control<\/p>\n

GOOD Vision invites investors, distributors, and practitioners to a live demonstration of the oka\u00b3y!\u2122 at the International Exhibition of Inventions Geneva:<\/p>\n

Location: PolyU Delegation Booth, Hall 2, Palexpo, CP 112, Route Fran\u00e7ois-Peyrot 30, 1218 Le Grand-Saconnex, Geneva, Switzerland Dates: 11-15 March 2026 Hashtag: #GOODVision<\/p>\n

The issuer is solely responsible for the content of this announcement.<\/p>\n

About GOOD Vision Technologies Co., LimitedGOOD Vision, a Hong Kong-based startup nurtured by PolyU, is dedicated to advancing the field of corneal reshaping technologies. With a focus on innovation, efficiency, and affordability, the company develops innovative solutions to empower eye practitioners and enhance the quality of eye care worldwide.<\/p>\n

For additional details about GOOD Vision and their innovative offerings, please visit https:\/\/www.linkedin.com\/company\/goodvisiontech <\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"GENEVA, SWITZERLAND – Media OutReach Newswire – 9 March 2026 – GOOD Vision Technologies Co., Limited, a pioneer…\n","protected":false},"author":2,"featured_media":27857,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[7944,16885,6697,65,2974,13445,2877,16882,16886,16880,16884,16883,338,17,1408,16881],"class_list":{"0":"post-27856","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-geneva","8":"tag-debut","9":"tag-freeform","10":"tag-from","11":"tag-geneva","12":"tag-global","13":"tag-good","14":"tag-in","15":"tag-okay","16":"tag-orthokeratology","17":"tag-polyu","18":"tag-precision","19":"tag-redefines","20":"tag-research","21":"tag-switzerland","22":"tag-to","23":"tag-vision"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116196661301807830","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/27856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=27856"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/27856\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/27857"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=27856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=27856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=27856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}